Navigation Links
Tibial Fracture Orthosis (Sarmiento style)

ProductsTibial Fracture Orthosis (Sarmiento style)
Company Sky Medical, Inc.
Item Tibial Fracture Orthosis (Sarmiento style)
Features 
  • Hook and loop straps adjust for volumetric changes
  • Interior closed cell foam padding
  • Early return to full function
  • Radiolucent
    • Description This Sarmiento style Patella-Tendon-Bearing brace is designed for the treatment of diaphyseal fractures of the tibia and fibula. The tibial crest provides post operative support following intra medullary nailing and removal of internal or external fixation. The brace allows for movement of joints above and below the fracture site, increasing vascularity and encouraging bone growth. For a more custom fit the brace may be modified with a heat gun and trimmed with cast scissors. A double axis shoe insert is provided to aid ambulation and prevent distal slippage.
    Info Sky Medical, Inc.
    Customer Service: (888) 769-6084
    Web site: http://www.skymedicalinc.com

    Related medicine products :

    1. Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
    2. Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
    3. Advance Uni-Comparental Knee Components - Uni Metal-backed Tibial Component
    4. Advance Uni-Compartmental Knee Components - Uni Metal-backed Tibial Component
    5. BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
    6. Genesis II Tibial Instrumentation
    7. MIS Tibial Stylus
    8. MIS Tibial Saw Guide
    9. Tibial Alignment Guide Assembly
    10. MIS Proximal Tibial Alignment Guide
    11. Pinn-ACL Tibial Guide2
    Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Survivors of childhood cancer less likely to marry 10291 1Survivors of childhood cancer less likely to marry 10291 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 1HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 3Statewide Drug Card Program Launching 59108 1